TGFB1 and cancer: Both immune cells and cancer cells have previously demonstrated the release of TGFβ, that on one side dampens the immune cell activity against cancer and on other side bring changes to the actin cytoskeleton of the cancer cells, conferring a change of cancer cell morphology13.